SEC Form 4 · accession 0001463205-15-000002
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Reay Code
Officer — Chief Science Officer · Director · 10% Owner
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 2:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 30, 2014 | A | 137,143 | $0.00 | A | 24,417,215 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are restricted from sale until the earlier of (i) Reporting Person's employment with Issuer is terminated, or (ii) the Issuer reports a "change in control" on Form 8-K.
- F2These shares were issued to Reporting Person as payment for $48,000 in fees due to Reporting Person for services as Issuer's Chief Science Officer, pursuant to a plan adopted by the Issuer's Board to retire outstanding accounts payable.
- F3Includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.